(2) SPIKE trial [59,60]: The aim of this study was to investigate the effects of DPP-IV inhibitor sitagliptin on the progression of carotid atherosclerosis using IMT in insulin-treated type 2 diabetic subjects. Here, INS is linked to carotid atherosclerosis.